Diabetes Flashcards

1
Q

What cells are glucagon secreted from?

A

Alpha - islet of langerhan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What cells produce insulin

A

Beta cells - islet of langerhan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Summarise glucagons effect and pathway on the body

A

1) G alpha S pathway - cAMP
2) Glycogen released
3) glucogenolysis increased
4) Increased blood glucose
5) Increase in gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does insulin promote glucose uptake?

A

1) GLUT 2 into cells
2)Glucose phosphorylation to ATP
3) ATP inhibits K+ channels
4) Depolarisation = activation Ca2+
5) Stimulates insulin vesicle release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does insulin get released by parasympathetic activation?

A

1) G alpha S pathway - cAMP
2) pka phosphorylates Ca2+ channels
3) stimulates release of insulin vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does insulin inhibit?

A

1) Glycogenolysis - breakdown of glycogen
) Gluconeogenesis - making glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What cells secrete somatostatin?

A

Delta - islet of langerhans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the effects of somatostatin?

A

1) Inhibits insulin
2) Supresses gastric absoprtion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 4 main causes for reduction in insulin release?

A

1) Decrease in beta cells
2) Decreased cell glucose uptake
3) Glucose exceeds renal threshold
4) Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the structure of insulin?

A

21 alpha chain peptide
30 beta chain peptide
linked with disulfide bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give example of RAPID insulin

A

Novorapid, Humalog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give example of SHORT insulin

A

Actarapid, humulin S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give example of INTERMEDIATE insulin

A

Humulin I, Insulatard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give example of LONG insulin

A

Lantus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the different equipment used for insulin

A

1) Vial and syrine
2) Reuseable pen
3) Disposable pen
4) innolet
5) insulin pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is lipohypertrophy

A

When you inject into the same area.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the implications of lipohypertrophy?

A

1) Decreases insulin absorption
2) Poor glucose control
3) Pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Summarise the 3 insulin regimes:

A

1) Basal-Bolus - Long acting insulin at night, rapid/short acting insulin with meals

2) Twice daily - Insulin taken morning and night

3) Inter - intermediate acting insulin 1/2 times daily

19
Q

Summarise MOA of metformin

A

1) Metformin inhibits mitrochondria chain complex 1
2) Decrease ATP, Increase AMP
3) AMPK activated
4) AMPK = decrease transcription for gluconeogenesis, Increase fat oxidation, Increase GLP-1

20
Q

Summarise MOA of sulfonylureas

A

1) Targets K+ Channels in beta cells
2) Inhibits channels
3) K+ cant leave - depolarisation
4) Ca2+ activate
5) Insulin released by vesicle exocytosis

21
Q

Summarise MOA of GLP-1 agonists

A

1) Targets Glucagon-like peptide receptor
2) Increase insulin secretion
3) Decreased gastric emptying and stops absorption of glucose in stomach

22
Q

Summarise MOA of DPP-4 inhibitors

A

1) Decreases breakdown of GLP-1 so that there is more incretin
2) Supresses gastric emptying and absorption
3) Increases insulin secretion - cAMP pathway

23
Q

Summarise MOA of PPAR gamma agonists

A

1) Enhances effectiveness of insulin
2) PPAR + RXR = receptor complex

24
Q

Summarise MOA of SGLT2 inhibitors

A

1) Inhibits SGL transporter in proximal tubule
2) Sodium and Glucose cant pass through from tubule into blood
3) Decreases glucose reabsorption in blood
4) Glucose excreted in urine

25
Q

Give examples of sulfonylureas

A

Gliclazide
‘ZIDES’

26
Q

Give examples of SGLT2

A

Dapagliflozin
‘FLOZINS’

27
Q

Give example of DPP-4 inhibitor

A

Sitagliptin
‘GLIPTINS’

28
Q

Give example of PPAR agonist

A

Pioglitazone

29
Q

Give example of GLP-1 agonist

A

Ozempic semiglutide

30
Q

How would you treat hypoglycaemia if a person can swallow

A

Glucose tablets, fresh juice, sweets, 40% glucose gel

31
Q

How would you treat hypoglycaemia if a person can’t swallow

A

Intramuscular glucagon
999 IV glucose

32
Q

Symptoms of DKA

A

ketone breath, nausea an vomiting, reduced consciousness, dehydration , hyperventilation

33
Q

Symptoms of Hypo

A

Confusion, impaired speech, mood changes, unconciousness

33
Q

Symptoms of T2 HHNKS

A

nausea and vomiting, dehydration, weakness and reduced consciousness

34
Q

What are the target glucose levels for non diabetics

A

3.4-5.8mmol/l

35
Q

What are target glucose level for diabetics

A

Before meals and waking - 4-7
90 mins after meals - 5-9

36
Q

What type of medication can cover up the symptoms of hypoglycaemia

A

Beta blockers - reduce sympathetic symptoms

37
Q

What blood glucose testing methods arent deemed appropriate for diagnosis

A

finger prick
urine stick

38
Q

What should the value of a HbA1c test be and what does this show

A

<48 mmol/l
shows average blood glucose levels over the past 8-12 weeks

39
Q

What are the 3 tests used for diabetes diagnosis and their results

A

1) Random plasma glucose = >11.1

2) Fasting plasma glucose = >7.0

3) Glucose tolerance test = >11.1

40
Q

When can HbA1c be used to diagnose

A

When value >48 + symptoms

41
Q

Summarise NICE guidelines for type 2 diabetes

A

1) METFORMIN
2) Sulfonylurea or pioglitazone or DPP-4 inhibitor
3) Up to triple therapy treatment
4) Insulin therapy
5) swapped to GLP-1 agonist if insulin isnt tolerated and BMI low enough (<35)

SGLT2 added if any cardiovascular risk of heart problems

42
Q

What is first line therapy for when metformin isnt tolerated

A

Sulfonylurea or SGLT2